Adverse Reactions: Long-term safety of PPIsTwo recent publications highlight the long-term safety of these medications, specifically concerning the development of hypomagnesemia and the increased risk of bone fractures. CADTH CornerDiabetes: From paper into practice. Canadian Agency for Drugs and Technologies in Health names new Canadian Drug Expert Committee members Clinical Notes: 2011 Canadian hypertension guidelines The 2011 Canadian hypertension guidelines provide comprehensive recommendations on a number of issues. Clinical Notes: Medical treatments for autism Review finds little evidence to support benefit for most medical treatments in children with autism spectrum disorders. Clinical Notes: Orlistat safety questioned Risk of acute kidney injury increased within one year of starting the antiobesity drug orlistat, study finds. Clinical Notes: PPI efficacy and safety in children with GERD PPIs not effective in reducing gastroesophageal reflux disease symptoms in infants, study finds. Drug News: September 2011 Benlysta: new IV immunosuppressant for SLE; Brilinta: new antiplatelet agent for prevention of CV events after ACS. Editorial: Ready for your first step? Business 2.0 sessions offer new, more rewarding path for your pharmacy business. Ethics and Issues: Asking about adherence What is the best way to ask patients about adherence? First automated dispensing machine accredited in Ontario College grants first approval for a pharmacist-controlled, user-interactive remote dispensing unit. Keeping an Eye on Cataracts Prevention, treatment and patient education. First Previous 1717 1718 1719 1720 1721 Next Last
